stocks logo

ORMP Financial Analysis

Oramed Pharmaceuticals Inc
$
2.100
0.000(0.000%)

ORMP Financial Analysis

FY2024Q3FY2024Q2FY2024Q1FY2023Q4FY2023Q3FY2023Q2FY2023Q1FY2022Q4FY2022Q3FY2022Q2FY2022Q1FY2021Q1FY2021Q4FY2021Q3FY2021Q2FY2021Q1FY2020Q4FY2020Q3FY2020Q2FY2020Q1
Total Revenue
0.00
0.00
-100.00%
0.00
-100.00%
0.00
-100.00%
0.00
-100.00%
674.00K
0.00%
666.00K
0.00%
681.00K
-0.29%
682.00K
0.15%
674.00K
1.35%
666.00K
-1.19%
674.00K
0.00%
683.00K
0.29%
681.00K
0.00%
665.00K
-1.34%
674.00K
0.00%
681.00K
0.00%
681.00K
-0.15%
674.00K
674.00K
Revenue from Goods & Services
0.00
0.00
-100.00%
0.00
-100.00%
0.00
-100.00%
0.00
-100.00%
674.00K
0.00%
666.00K
0.00%
681.00K
-0.29%
682.00K
0.15%
674.00K
1.35%
666.00K
-1.19%
674.00K
0.00%
683.00K
0.29%
681.00K
0.00%
665.00K
-1.34%
674.00K
0.00%
681.00K
0.00%
681.00K
-0.15%
674.00K
674.00K
Cost of Goods Sold
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit
0.00
0.00
-100.00%
0.00
-100.00%
0.00
-100.00%
0.00
-100.00%
674.00K
0.00%
666.00K
0.00%
681.00K
-0.29%
682.00K
0.15%
674.00K
1.35%
666.00K
-1.19%
674.00K
0.00%
683.00K
0.29%
681.00K
0.00%
665.00K
-1.34%
674.00K
0.00%
681.00K
0.00%
681.00K
-0.15%
674.00K
674.00K
Selling General & Administrative Expenses
3.09M
-13.13%
3.14M
-29.79%
2.96M
-49.57%
3.88M
-62.80%
3.56M
-59.91%
4.47M
-63.07%
5.87M
-50.71%
10.42M
28.77%
8.87M
30.48%
12.09M
118.53%
11.92M
36.46%
6.50M
109.51%
8.09M
118.85%
6.80M
130.08%
5.53M
17.45%
6.50M
109.51%
3.70M
22.21%
2.96M
-37.92%
4.71M
3.10M
Research & Development Expense
2.24M
134.27%
1.44M
-20.81%
1.18M
-73.37%
1.77M
-75.73%
957.00K
-82.10%
1.82M
-80.16%
4.43M
-24.14%
7.28M
24.52%
5.35M
-2.82%
9.18M
137.24%
5.84M
-8.95%
5.77M
185.56%
5.84M
96.90%
5.50M
185.82%
3.87M
16.54%
5.77M
185.56%
2.97M
34.91%
1.93M
-50.14%
3.32M
2.02M
Other Operating Expense - Net
0.00
-100.00%
0.00
0.00
0.00
-663.00K
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Operating Profit
-3.09M
6.77%
-3.14M
-17.30%
-2.96M
-43.13%
-3.88M
-60.20%
-2.89M
-64.67%
-3.79M
-66.80%
-5.21M
-53.71%
-9.74M
31.44%
-8.19M
33.85%
-11.42M
134.53%
-11.25M
39.60%
-5.83M
139.89%
-7.41M
145.61%
-6.12M
169.04%
-4.87M
20.58%
-5.83M
139.89%
-3.02M
28.66%
-2.27M
-44.24%
-4.04M
-2.43M
Financing Income- Net
-15.42M
3843.73%
13.97M
463.88%
4.50M
181.53%
17.17M
1610.46%
-391.00K
-137.74%
2.48M
608.00%
1.60M
193.57%
1.00M
1.04M
110.14%
350.00K
34.62%
544.00K
-1531.58%
257.00K
35.98%
0.00
-100.00%
493.00K
156.77%
260.00K
55.69%
257.00K
35.98%
-302.00K
47.32%
192.00K
-22.89%
167.00K
189.00K
Interest Expense
15.42M
3843.73%
-13.97M
463.88%
-4.50M
181.53%
-17.17M
1610.46%
391.00K
-137.74%
-2.48M
608.00%
-1.60M
193.57%
-1.00M
-1.04M
110.14%
-350.00K
34.62%
-544.00K
-1531.58%
-257.00K
35.98%
0.00
-100.00%
-493.00K
156.77%
-260.00K
55.69%
-257.00K
35.98%
302.00K
47.32%
-192.00K
-22.89%
-167.00K
-189.00K
Other Non-Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-100.00%
0.00
0.00
0.00
0.00
224.00K
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Income before Taxes
-18.51M
463.61%
10.84M
-925.44%
1.53M
-142.48%
13.30M
-252.20%
-3.28M
-54.09%
-1.31M
-88.14%
-3.61M
-66.28%
-8.74M
21.57%
-7.15M
27.16%
-11.07M
140.17%
-10.71M
32.23%
-5.57M
119.03%
-7.19M
139.85%
-5.63M
146.28%
-4.61M
24.95%
-5.57M
119.03%
-3.00M
31.40%
-2.28M
-43.91%
-3.69M
-2.54M
Income Taxes
1.13M
1.63M
0.00
0.00
0.00
-100.00%
0.00
0.00
0.00
100.00K
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Income after Tax
-19.64M
498.11%
9.20M
-800.99%
1.53M
-142.48%
13.30M
-252.20%
-3.28M
-54.72%
-1.31M
-88.14%
-3.61M
-66.28%
-8.74M
21.57%
-7.25M
28.94%
-11.07M
140.17%
-10.71M
32.23%
-5.57M
119.03%
-7.19M
139.85%
-5.63M
146.28%
-4.61M
24.95%
-5.57M
119.03%
-3.00M
31.40%
-2.28M
-43.91%
-3.69M
-2.54M
Minority Interest
-23.00K
-62.90%
-8.00K
-93.28%
-2.00K
-99.07%
-40.00K
-79.27%
-62.00K
-67.88%
-119.00K
-77.72%
-216.00K
-23.67%
-193.00K
-42.04%
-193.00K
-53.83%
-534.00K
-283.00K
36.06%
0.00
-333.00K
-418.00K
0.00
0.00
0.00
0.00
0.00
0.00
Income Available to Common Shares
-19.62M
508.91%
9.21M
-871.52%
1.54M
-145.24%
13.34M
-256.10%
-3.22M
-54.36%
-1.19M
-88.66%
-3.40M
-67.43%
-8.54M
24.66%
-7.06M
35.59%
-10.53M
128.58%
-10.43M
32.13%
-5.57M
119.03%
-6.85M
128.74%
-5.21M
127.98%
-4.61M
24.95%
-5.57M
119.03%
-3.00M
31.40%
-2.28M
-43.91%
-3.69M
-2.54M
EPS - Basic
-0.48
500.00%
0.22
-833.33%
0.04
-150.00%
0.33
-250.00%
-0.08
-55.56%
-0.03
-88.89%
-0.08
-70.37%
-0.22
4.76%
-0.18
5.88%
-0.27
58.82%
-0.27
22.73%
-0.23
53.33%
-0.21
61.54%
-0.17
70.00%
-0.17
-19.05%
-0.23
53.33%
-0.13
-0.00%
-0.10
-56.52%
-0.21
-0.15
EPS - Diluted
-0.48
500.00%
0.22
-833.33%
0.04
-150.00%
0.32
-245.45%
-0.08
-55.56%
-0.03
-88.89%
-0.08
-70.37%
-0.22
4.76%
-0.18
5.88%
-0.27
58.82%
-0.27
22.73%
-0.23
53.33%
-0.21
61.54%
-0.17
70.00%
-0.17
-19.05%
-0.23
53.33%
-0.13
-0.00%
-0.10
-56.52%
-0.21
-0.15
EBIT
-3.09M
6.77%
-3.14M
-17.30%
-2.96M
-43.13%
-3.88M
-60.20%
-2.89M
-64.67%
-3.79M
-66.80%
-5.21M
-53.71%
-9.74M
31.44%
-8.19M
33.85%
-11.42M
134.53%
-11.25M
39.60%
-5.83M
139.89%
-7.41M
145.61%
-6.12M
169.04%
-4.87M
20.58%
-5.83M
139.89%
-3.02M
28.66%
-2.27M
-44.24%
-4.04M
-2.43M
EBITDA
-3.04M
6.97%
-3.08M
-17.60%
-2.91M
-43.80%
-3.82M
-60.67%
-2.84M
-65.27%
-3.74M
-67.21%
-5.17M
-54.00%
-9.72M
31.55%
-8.17M
34.22%
-11.40M
135.58%
-11.24M
39.67%
-5.83M
139.81%
-7.39M
145.14%
-6.09M
168.16%
-4.84M
19.95%
-5.83M
139.81%
-3.02M
28.79%
-2.27M
-44.31%
-4.04M
-2.43M
Depreciation Depletion & Amortization
52.00K
-3.70%
54.00K
3.85%
56.00K
51.35%
53.00K
211.76%
54.00K
260.00%
52.00K
246.67%
37.00K
236.36%
17.00K
-10.53%
15.00K
-46.43%
15.00K
-46.43%
11.00K
-8.33%
2.00K
19.00K
850.00%
28.00K
833.33%
28.00K
1300.00%
2.00K
2.00K
-50.00%
3.00K
2.00K
0.00

ORMP FAQs

What is ORMP's PE Ratio in 2025/4/4?

ORMP's PE ratio in April 4, 2025 is -4.38. This indicates the price investors are willing to pay for $1 of earnings.

What is ORMP's PS Ratio in 2025/4/4?

What is ORMP's Dividend Yield in 2024/Q4?

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

Is ORMP earnings result positive or negative?How should I trade on ORMP earnings?